{"id":"W4416630327","doi":"10.1158/1078-0432.30708732","title":"Supplementary Material 1 from Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial","year":2025,"lang":"","type":"article","venue":"","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Amgen Canada; Sanofi; Amgen","keywords":"Cabazitaxel; Prostate; Prostate cancer; Phases of clinical research; Clinical trial; Tirapazamine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002421861,0.001288808,0.001451056,0.0006862914,0.0007262549,0.00156856,0.001388761,0.001354664,0.6967931],"category_scores_gemma":[0.01752047,0.0008956366,0.001178866,0.001058764,0.000240072,0.001008532,0.0006852056,0.001788793,0.08453967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001224678,"about_ca_system_score_gemma":0.002447089,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001351414,"about_ca_topic_score_gemma":0.005210801,"domain_scores_codex":[0.9988434,0.0004836186,0.000198841,0.0001658297,0.0001809921,0.0001272007],"domain_scores_gemma":[0.99201,0.004791509,0.0008500555,0.000629711,0.0008659113,0.0008528794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02012997,0.0008942441,0.0009254783,0.007794754,0.0004650166,0.0001541121,0.00003100552,0.0007532661,0.0006279745,0.001293033,0.9143971,0.05253412],"study_design_scores_gemma":[0.2004958,0.008831885,0.01779585,0.005937838,0.001566319,0.001576313,0.00008901527,0.002124202,0.002251827,0.01181539,0.7473483,0.0001672695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.00297818,0.001891684,0.001740529,0.002572349,0.001996002,0.006544698,0.960747,0.00042295,0.02110655],"genre_scores_gemma":[0.03406732,0.004228849,0.01334815,0.01087892,0.003284465,0.04647411,0.8151445,0.0008082822,0.07176542],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.6967931,"threshold_uncertainty_score":0.4324878,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01152829888838081,"score_gpt":0.3039740035212628,"score_spread":0.292445704632882,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}